Smith & Nephew vs Steris
SNN and STE side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How SNN and STE compare
Steris grew revenue faster over the last twelve months (8.4% versus 6.1% for Smith & Nephew).
Steris pays a dividend yielding 0.86%; Smith & Nephew does not pay one.
Steris scores higher on the StockData Score (21 against 6 for Smith & Nephew), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | SNN | STE |
|---|---|---|
| Size and price | ||
| Market cap | – | $22.1B |
| Share price | $29.70 | $227.12 |
| Change, 1 year | −17.0% | −4.1% |
| Change, 5 years | −20.1% | 1.1% |
| Beta (5Y) | 0.63 | 0.77 |
| Employees | 18K | 17K |
| StockData Score | ||
| Total score | 6 | 21 (better) |
| Valuation score | 0 | 4 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 1 | 4 (better) |
| Health score | 4 | 6 (better) |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | – | 27.8× |
| P/S | – | 3.7× |
| P/B | – | 3.1× |
| EV/EBITDA | – | 14.4× |
| P/FCF | – | 23.9× |
| PEG | – | 0.29 |
| FCF yield | – | 4.2% |
| Fair value | – | $255.07 |
| Margin of safety | – | 11.0% |
| Growth | ||
| Revenue growth (TTM) | 6.1% | 8.4% (better) |
| Revenue growth, 5Y average | 6.2% | 13.8% (better) |
| Net income growth (TTM) | – | 24.5% |
| EPS growth (TTM) | 52.3% (better) | 25.5% |
| EPS growth, 5Y average | 6.9% | 11.4% (better) |
| Profitability | ||
| Gross margin | 68.0% (better) | 44.4% |
| Operating margin | 12.9% | 18.9% (better) |
| Net margin | – | 13.3% |
| FCF margin | – | 15.3% |
| Return on equity | – | 11.4% |
| Return on invested capital | 13.0% (better) | 9.9% |
| Financial health | ||
| Debt / equity | 0.10 (better) | 0.26 |
| Net debt / EBITDA | −0.31 | 0.86 (better) |
| Interest coverage | 5.7× | 18.8× (better) |
| Current ratio | 2.14 (better) | 1.91 |
| Altman Z-score | – | 5.23 |
| Piotroski F-score | – | 9 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.86% |
| Payout ratio | – | 30.7% |
| Years of dividend growth | – | 9 |
| Dividend growth, 5Y average | – | 9.4% |
| Buyback yield | – | 1.5% |
| Shareholder yield | – | 2.4% |
| Ownership | ||
| Held by institutions | 4.2% | 97.4% |
| Held by insiders | 25.1% | 0.34% |
| Insider net buying, 12 months | – | −$9.8M |
| Short interest, % of float | – | 2.9% |
Go deeper
- SNN stock overview
- SNN income statement
- SNN valuation and score
- STE stock overview
- STE income statement
- STE valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.